In recent decades there have been some big advances in developing new cancer medicines, such as Herceptin, the targeted drug to treat women diagnosed with HER2-positive breast cancer. Despite these successes, cancer remains ...
Feb 23, 2021
0
8
ProAgio, a drug developed by Georgia State University biology professor Zhi-Ren Liu and his team, is effective at treating pancreatic cancer and prolonging survival in mice, according to a study published in the journal Cellular ...
Feb 9, 2021
0
1
Some of the most commonly used drugs for treating hereditary breast and ovarian cancers may not work the way we thought they did, according to new University of Colorado Boulder research.
Feb 3, 2021
0
45
SORLA is a protein trafficking receptor that has been mainly studied in neurons, but it also plays a role in cancer cells. Professor Johanna Ivaska's research group at Turku Bioscience observed that SORLA functionally contributes ...
Jan 29, 2021
0
2
One more piece of the puzzle has fallen into place behind a new drug whose anti-cancer potential was developed at the University of Alberta and is set to begin human trials this year, thanks to newly published research.
Jan 21, 2021
0
6
The U.S. pharmaceutical industry has innovated in response to the pandemic, providing not only vaccines but also therapies to treat people with COVID-19. But an outdated law designed to spur development of lifesaving drugs ...
Jan 14, 2021
0
2
A drug used to treat pulmonary hypertension significantly reduced the capacity of tumor cells to migrate and invade other tissues in trials involving pancreatic, ovarian, breast cancer, and leukemia cell lines. Furthermore, ...
Dec 15, 2020
0
59
The use of puberty blocking drugs to treat adolescents with gender dysphoria or incongruence has recently come under scrutiny following a decision by the UK High Court. Three judges ruled that children under 16 were unlikely ...
Dec 10, 2020
0
4
The first study to compare molecular landscapes of early-onset and late-onset appendiceal cancer has revealed distinct non-silent mutations in the tumors of younger patients, setting the stage for the development of potential ...
Dec 9, 2020
0
0
More than 1.2 million people in the US prevented facing death following a cancer diagnosis, between the year 2000 and 2016, thanks to ever improving treatment options—a large new national study shows.
Nov 9, 2020
1
55
